BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10195921)

  • 21. Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1051-9. PubMed ID: 10195935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes.
    Tanaka M; Jingami H; Otani H; Cho M; Ueda Y; Arai H; Nagano Y; Doi T; Yokode M; Kita T
    J Biol Chem; 1993 Jun; 268(17):12713-8. PubMed ID: 8509406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
    Wu X; Sakata N; Lui E; Ginsberg HN
    J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells.
    Rea TJ; DeMattos RB; Homan R; Newton RS; Pape ME
    Biochim Biophys Acta; 1996 Jan; 1299(1):67-74. PubMed ID: 8555254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
    Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
    Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools.
    Benoist F; Grand-Perret T
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1229-35. PubMed ID: 8857918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance.
    Krause BR; Pape ME; Kieft K; Auerbach B; Bisgaier CL; Homan R; Newton RS
    Arterioscler Thromb; 1994 Apr; 14(4):598-604. PubMed ID: 8148358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
    Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
    J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
    Vaziri ND; Liang K
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
    Burnett JR; Telford DE; Barrett PH; Huff MW
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):10-8. PubMed ID: 16427354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesis.
    Ooyen C; Zecca A; Zanelli T; Catapano AL
    Atherosclerosis; 1997 Apr; 130(1-2):143-52. PubMed ID: 9126658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of individual amino acids on ApoB100 and Lp(a) secretion by HepG2 cells.
    Cianflone K; Zhang Z; Vu H; Kohen-Avramoglu R; Kalant D; Sniderman AD
    J Biol Chem; 1996 Nov; 271(46):29136-45. PubMed ID: 8910570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid.
    Theriault A; Wang Q; Van Iderstine SC; Chen B; Franke AA; Adeli K
    J Lipid Res; 2000 Dec; 41(12):1969-79. PubMed ID: 11108730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
    Kaptein A; de Wit EC; Princen HM
    Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
    Telford DE; Lipson SM; Barrett PH; Sutherland BG; Edwards JY; Aebi JD; Dehmlow H; Morand OH; Huff MW
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2608-14. PubMed ID: 16210564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.
    Miyazaki A; Kanome T; Watanabe T
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):463-9. PubMed ID: 16503866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic very low density lipoprotein secretion and low density lipoprotein receptor expression in the mouse and hamster.
    Spady DK; Willard MN; Meidell RS
    J Biol Chem; 2000 Sep; 275(35):27005-12. PubMed ID: 10869364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.